BeyondSpring Inc. Ordinary Shares
BYSI Real Time Price USDRecent trades of BYSI by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by BYSI's directors and management
Government lobbying spending instances
-
$20,000 Apr 19, 2024 Issue: Health Issues
-
$20,000 Jan 22, 2024 Issue: Health Issues
-
$20,000 Oct 20, 2023 Issue: Health Issues
-
$20,000 Jul 20, 2023 Issue: Health Issues
-
$20,000 Apr 20, 2023 Issue: Health Issues
-
$20,000 Jan 20, 2023 Issue: Health Issues
-
$20,000 Oct 28, 2022 Issue: Health Issues
-
$20,000 Oct 20, 2022 Issue: Health Issues
-
$20,000 Jul 20, 2022 Issue: Health Issues
-
$20,000 Apr 20, 2022 Issue: Health Issues
-
$20,000 Oct 20, 2021 Issue: Health Issues
-
$20,000 Sep 24, 2021 Issue: Health Issues
-
$20,000 Sep 24, 2021 Issue: Health Issues
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Cancer treatment with combination of plinabulin and taxane Mar. 24, 2020
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of BYSI in WallStreetBets Daily Discussion
Recent insights relating to BYSI
Recent picks made for BYSI stock on CNBC
ETFs with the largest estimated holdings in BYSI
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view BYSI Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.